Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-02-04

FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Hydralazine Hydrochloride submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

SUPPL AP for HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)